Stay updated with breaking news from Tissue Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences (NASDAQ:IART – Get Rating) had its price objective lowered by JMP Securities from $75.00 to $65.00 in a report published on Thursday, The Fly reports. A number of other brokerages also recently weighed in on IART. Citigroup reduced their target price on Integra LifeSciences from $60.00 to $59.00 and set a neutral rating […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) – Investment analysts at Oppenheimer decreased their Q2 2023 earnings estimates for shares of Integra LifeSciences in a report issued on Thursday, April 27th. Oppenheimer analyst S. Lichtman now forecasts that the life sciences company will earn $0.78 per share for the quarter, down from their prior […]
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.75 to $0.79 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $396 million to $400 million, compared to the consensus revenue estimate […]
Should You Buy or Sell Integra LifeSciences Stock? Get The Latest IART Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Integra LifeSciences (NASDAQ:IART – Get Rating) announced its quarterly earnings data on Wednesday. The life sciences company reported $0.74 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.74, Briefing.com reports. The firm had revenue of $380.85 million for the quarter, compared to analysts’ expectations of $373.21 million. Integra LifeSciences had a […]